GPCR NewsJun 1, 20221 minGPCR Industry NewsCrinetics Presents Clinical And Research Results At ENDO 2022June 2022 "CRN04894 Selected for Oral Presentation SAN DIEGO, June 8, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), announced...
GPCR NewsApr 1, 20221 minGPCR Industry NewsCrinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock OfferingApril 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused...
GPCR NewsMar 1, 20221 minGPCR Industry NewsCrinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief Commercial Officer "SAN DIEGO –...
GPCR NewsDec 1, 20211 minGPCR Industry NewsCrinetics Pharmaceuticals announced the formation of an independently operated new company...December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company, Radionetics Oncology....